Gallery: These 12 stocks will benefit most from Biden’s $1 trillion infrastructure plan, according to Bank of America (Business Insider)
Shares of Johnson & Johnson inched 0.68% higher to $174.93 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.28% to 4,536.95 and the Dow Jones Industrial Average rising 0.37% to 35,443.82. This was the stock’s second consecutive day of gains. Johnson & Johnson closed $4.99 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. rose 0.28% to $400.58, Merck & Co. Inc. rose 1.23% to $77.12, and Pfizer Inc. rose 1.74% to $46.84. Trading volume (4.2 M) remained 1.5 million below its 50-day average volume of 5.7 M.